NovoCure Ltd
NVCR
17 insider filings · Latest: Apr 28, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | Feb 27 9:36 PM | WILHELMUS GROENHUYSEN | Proposed Sale | 7,211 | $20.02 | $144.4K | — | View → |
| Feb 27, 2025 | Feb 27 9:28 PM | FRANCIS LEONARD | Proposed Sale | 12,266 | $20.02 | $245.6K | — | View → |
| Jan 13, 2025 | Jan 13 10:28 PM | MUKUND PARAVASTHU | Proposed Sale | 2,160 | $26.75 | $57.8K | — | View → |
| Jan 2, 2025 | Jan 2 9:25 PM | WILHELMUS C. GROENHUYSEN | Proposed Sale | 266,085 | $29.80 | $7.9M | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Apr 28 8:27 PM | Anthony W VernonDirector | Option Exercise | 21,500 | $11.39 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 9:32 PM | Arye Barak BenGeneral Counsel | Grant/Award | 73,340 | $13.30 | 73,340(D) | View → |
| Mar 3, 2026 | Mar 5 9:32 PM | Uri WeinbergChf Medical and Innovation Ofr | Grant/Award | 73,340 | $13.30 | 73,340(D) | View → |
| Mar 3, 2026 | Mar 5 9:31 PM | Christoph BrackmannChief Financial Officer | Grant/Award | 80,674 | $13.30 | 80,674(D) | View → |
| Mar 3, 2026 | Mar 5 9:31 PM | Frank X LeonardChief Executive Officer | Grant/Award | 216,388 | $13.30 | 216,388(D) | View → |
| Mar 3, 2026 | Mar 5 9:31 PM | Mukund ParavasthuChief Operating Officer | Grant/Award | 66,006 | $13.30 | 66,006(D) | View → |
| Mar 3, 2026 | Mar 5 9:31 PM | Michal Nath PuriChief Human Resources Officer | Grant/Award | 58,672 | $13.30 | 58,672(D) | View → |
| Mar 3, 2026 | Mar 5 9:30 PM | William F DoyleDirector, Executive Chairman | Grant/Award | 288,517 | $13.30 | 288,517(D) | View → |